XENGLU
Xenglu Met 12.5/1000mg 14's
KES 1,288
Price per Packets
In Stock
Overview
Xenglu Met 12.5/1000mg Tablets (14 pack) combine empagliflozin 12.5mg, an SGLT2 inhibitor, with metformin 1000mg for type 2 diabetes needing combination therapy. Empagliflozin helps the kidneys flush excess glucose out through the urine, adding proven heart and kidney protection and modest weight benefit, while metformin curbs the liver's glucose output, together giving stronger blood sugar control. The 12.5mg twice-daily strength is part of a split-dose regimen.
Directions for Use
This is a prescription medicine. Take only as directed by your doctor or pharmacist. Take as prescribed, typically twice daily with meals to minimise stomach upset, swallowed whole with water. Maintain good hydration, continue diet and exercise measures, and monitor blood sugar as advised. Do not change the dose without medical guidance. Confirm the active with your pharmacist.
Seek urgent care for nausea, vomiting, abdominal pain or rapid breathing. Possible ketoacidosis even with near-normal glucose (the empagliflozin component). Genital thrush and urinary infections are more likely. Treatment pauses during serious illness, before surgery or contrast scans (both components). Caution in kidney impairment; limit alcohol (rare lactic acidosis risk with metformin). May cause dizziness from fluid loss with diuretics. Not for type 1 diabetes. Confirm the active on the pack. This product information is for general guidance only and does not replace professional medical advice. Always consult a qualified healthcare provider before starting any new medication or supplement. Keep all medicines out of reach of children.
Empagliflozin 12.5mg and Metformin hydrochloride 1000mg (active ingredients. Confirm on packaging).